Skip to main content
. 2021 Dec 8;9(3):e02038-21. doi: 10.1128/spectrum.02038-21

FIG 1.

FIG 1

Predicted and detected bioactive secondary metabolites (BSMs) produced by the Pseudomonas strains used in this study. Metabolites with biosynthetic gene clusters (BGCs) predicted by antiSMASH 6.0 (42) and detected ([M+H]+ or [M+2H]+, the latter is indicated with an asterisk) by UPLC-qTOF MS in crude cell-free supernatant after growth in CAA medium are represented by green squares, while undetected BSMs are represented by light red squares. Detected m/z and mass errors in parts per million (based on one measurement from one strain [orfamides, CMR12a; achromobactin, JV497; phenazines, CMR12a; 2,4-diacetylphloroglucinol, Pf-5]) corresponding to the main variant(s) (indicated with the letters) detected are presented. The data are representative of the two independent repetitions.